Synthesis and anticonvulsant activity of 5-phenyl-[1,2,4]-triazolo[4,3-a] quinolines

Archiv der Pharmazie

Volumn 341, Issue 12, 2008, Pages 774-779

  Guan, Li Ping ^a   Jin, Qing Hao ^a   Wang, Shou Feng ^a   Li, Fu Nan ^a   Quan, Zhe Shan ^a  

^a YANBIAN UNIVERSITY   (China)

Author keywords

1,2,4 triazolo 4,3 a quinoline; Anticonvulsant activity; Maximal electroshock; Synthesis

Indexed keywords

2 CHLORO 4 PHENYL 1,2 DIHYDRONAPHTHALENE; 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE DERIVATIVE; 6,9 DICHLORO 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 6,9 DIMETHOXY 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 (HEPTYLOXY) 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 (HEXYLOXY) 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 (OCTYLOXY) 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 (PENTYLOXY) 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 BENZYL 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 BROMO 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 BUTOXY 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 CHLORO 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 ETHOXY 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 FLUORO 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 HEXYLOXY 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 METHOXY 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7 METHYL 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7,8 DIMETHOXY 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 7,8 DIMETHYLENEDIOOXY 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; 9 METHYL 5 PHENYL[1,2,4] TRIAZOLO[4,3 A]QUINOLINE; ETHYL 3 OXO 3 PHENYLPROPANOATE; NAPHTHALENE DERIVATIVE; PHENYTOIN; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANILINE COMPOUNDS; ANIMALS; ANTICONVULSANTS; CYCLIZATION; ELECTROSHOCK; MICE; NAPHTHALENES; QUINOLONES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 57049130035     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200800116     Document Type: Article

References (14)

1. W. Loscher, Eur. J. Pharmacol. 1998, 342, 1-13.
2. I. E. Leppik, Epilepsia 1994, 35, 29-40.
3. E. Perucca, Br. J. Clin. Pharmacol. 1996, 42, 531-543.
4. Z. Lin, P. K. Kadaba, Med. Res. Rev. 1997, 17, 537-572.
5. Y. A. Al-Soud, N. A. Al-Masoudi, A.-R. Ferwanah, Bioorg. Med. Chem. 2003, 8, 1701-1708.
6. L. P. Guan, Q. H. Jin, G. R. Tian, K. Y. Chai, Z. S. Quan, J. Pharm. Pharm. Sci. 2007, 3, 254-262.
7. J. Chen, X. Y. Sun, K. Y. Chai, J. S. Lee, et al., Bioorg. Med. Chem. 2007, 15, 6775-6781.
8. L. P. Guan, X. Y. Sun, G. R. Tian, K. Y. Chi, X. S. Quan, Turk. J. Chem. 2008, 32, 181-189.
9. L. J. Huang, M. C. Hsieh, C. M. Teng, K. H. Lee, S. C. Kuo, Bioorg. Med. Chem. 1998, 6, 1657-1662.
10. K. Hino, K. Kawashima, M. Oka, H. Uno, J. I. Matsumoto, Chem. Pharm. Bull. 1989, 1, 190-192.
11. J. D. Albright, D. B. Moran, W. B. Wright Jr., J. B. Collins, et al., J. Med. Chem. 1981, 24, 592-600.
12. J. B. Medwid, R. Paul, J. S. Baker, J. A. Brockman, et al., J. Med. Chem. 1990, 33, 1230-1241.
13. J. B. Jr. Hester, P. von Voigtlander, J. Med. Chem. 1979, 22, 1390-1398.
14. J. B. Jr. Hester, A. D. Rudzik, P. von Voigtlander, J. Med. Chem. 1980, 23, 402-405.